IL6 and neoplasm: In induced senescent hepatocellular carcinoma, CCL2 attracts a group of CCR2+ subpopulations of cells, blocking tumor immune surveillance by binding to NK cells; similarly, IL-6 in the SASP can recruit bone marrow suppressor cells expressing CD11b+ and Cr-1 to reduce the immune monitoring effect of antitumor T cells.